Cervical cancer heterogeneity: a constant battle against viruses and drugs

Cervical cancer is the first identified human papillomavirus (HPV) associated cancer and the most promising malignancy to be eliminated. However, the ever-changing virus subtypes and acquired multiple drug resistance continue to induce failure of tumor prevention and treatment. The exploration of ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Qian, Wang, Liangliang, Zhang, Cong, Hong, Zhenya, Han, Zhiqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9670454/
https://www.ncbi.nlm.nih.gov/pubmed/36397138
http://dx.doi.org/10.1186/s40364-022-00428-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9670454/
https://www.ncbi.nlm.nih.gov/pubmed/36397138
http://dx.doi.org/10.1186/s40364-022-00428-7

Ejemplares similares